Literature DB >> 1869970

Noninvasive grading of musculoskeletal tumors using PET.

L P Adler1, H F Blair, J T Makley, R P Williams, M J Joyce, G Leisure, N al-Kaisi, F Miraldi.   

Abstract

Twenty-five patients with mass lesions involving the musculoskeletal system were studied with positron emission tomography (PET) in order to determine if a relationship exists between histologic grade and tumor uptake of [fluorine-18]2-deoxy-2-fluoro-D-glucose (FDG). There were 6 benign lesions and 19 malignant lesions of various grades. A high correlation (Rho = 0.83) was found between the normalized uptake of tracer and the NCl grade. The high-grade malignancies had significantly greater (p = 0.0091) uptake of FDG than the combination of benign lesions and low-grade malignancies. All lesions with a normalized uptake value of 1.6 or greater were high-grade, while all lesions less than 1.6 represented either benign tumors or low grade malignancies. This strong relationship between FDG uptake and grade among neoplasms from a wide variety of cell types within a single organ system suggests that the technique may be useful in predicting grade even when the cell type is unknown.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1869970

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  38 in total

1.  FDG-PET for preoperative differential diagnosis between benign and malignant soft tissue masses.

Authors:  J Aoki; H Watanabe; T Shinozaki; K Takagishi; M Tokunaga; Y Koyama; N Sato; K Endo
Journal:  Skeletal Radiol       Date:  2003-01-24       Impact factor: 2.199

Review 2.  Clinical applications of molecular imaging in sarcoma evaluation.

Authors:  Rodney J Hicks; Guy C Toner; Peter F M Choong
Journal:  Cancer Imaging       Date:  2005-06-21       Impact factor: 3.909

3.  The role of [18F]-fluorodeoxyglucose positron emission tomography in predicting plexiform neurofibroma progression.

Authors:  Michael J Fisher; Sandip Basu; Eva Dombi; Jian Q Yu; Brigitte C Widemann; Avrum N Pollock; Avital Cnaan; Hongming Zhuang; Peter C Phillips; Abass Alavi
Journal:  J Neurooncol       Date:  2007-12-11       Impact factor: 4.130

4.  Nonsurgical giant cell tumour of the tendon sheath or of the diffuse type: are MRI or 18F-FDG PET/CT able to provide an accurate prediction of long-term outcome?

Authors:  Laurent Dercle; Roland Chisin; Samy Ammari; Quentin Gillebert; Monia Ouali; Cyril Jaudet; Jean-Pierre Delord; Lawrence Dierickx; Slimane Zerdoud; Martin Schlumberger; Frédéric Courbon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-11-01       Impact factor: 9.236

5.  (18)F-FDG PET/CT with Contrast Enhancement for Evaluation of Axillary Lymph Node Involvement in T1 Breast Cancer.

Authors:  Eun Jung Kong; Kyung Ah Chun; Ihn Ho Cho; Soo Jung Lee
Journal:  Nucl Med Mol Imaging       Date:  2010-06-15

Review 6.  Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.

Authors:  P Rigo; P Paulus; B J Kaschten; R Hustinx; T Bury; G Jerusalem; T Benoit; J Foidart-Willems
Journal:  Eur J Nucl Med       Date:  1996-12

7.  Molecular mechanism underlying the detection of colorectal cancer by 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography.

Authors:  Kunihiko Izuishi; Yuka Yamamoto; Takanori Sano; Ryusuke Takebayashi; Yoshihiro Nishiyama; Hirohito Mori; Tsutomu Masaki; Asahiro Morishita; Yasuyuki Suzuki
Journal:  J Gastrointest Surg       Date:  2011-11-08       Impact factor: 3.452

Review 8.  PET/CT in primary musculoskeletal tumours: a step forward.

Authors:  A Lakkaraju; C N Patel; K M Bradley; A F Scarsbrook
Journal:  Eur Radiol       Date:  2010-06-25       Impact factor: 5.315

9.  Peripheral nerve schwannoma: two cases exhibiting increased FDG uptake in early and delayed PET imaging.

Authors:  Kenichiro Hamada; Takafumi Ueda; Ichiro Higuchi; Atsuo Inoue; Noriyuki Tamai; Akira Myoi; Yasuhiko Tomita; Katsuyuki Aozasa; Hideki Yoshikawa; Jun Hatazawa
Journal:  Skeletal Radiol       Date:  2004-10-09       Impact factor: 2.199

10.  Fluorodeoxyglucose-positron emission tomography in adenocarcinomas of the distal esophagus and cardia.

Authors:  Katja Ott; Wolfgang A Weber; Ulrich Fink; Hermann Helmberger; Karen Becker; Hubert J Stein; James Müller; Markus Schwaiger; Jörg Rüdiger Siewert
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.